SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-009336
Filing Date
2024-03-26
Accepted
2024-03-26 07:30:15
Documents
14
Period of Report
2024-03-25
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240325_8k.htm   iXBRL 8-K 46816
  Complete submission text file 0001437749-24-009336.txt   182211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nby-20240325.xsd EX-101.SCH 3401
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240325_def.xml EX-101.DEF 11421
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240325_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240325_pre.xml EX-101.PRE 11581
17 EXTRACTED XBRL INSTANCE DOCUMENT nby20240325_8k_htm.xml XML 2850
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 24780895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)